Ethical Overview of Pharmaceutical Industry Policies in Turkey from Various Perspectives

Journal Title: Turkish Journal of Pharmaceutical Sciences - Year 2017, Vol 14, Issue 3

Abstract

Objectives: Countries’ national drug policies include all key stakeholders (pharmacists, physicians, pharmaceutical firms, and patients) in the public, the private sector, and the field of pharmacy. The aim of this study was to outline pharmaceutical patents and data protection, orphan drugs, drug pricing, and surplus goods regarding pharmacoeconomics, promotions, inspections in the pharmaceutical industry, and policies in pharmacies with respect to buying and selling drugs, and to discuss ethics in particular. Materials and Methods: Written laws in force relating to drugs in Turkey constitute the materials of this study. Results: Essential medicines must always be accessible. Both governments and pharmaceutical companies must fulfill the obligations imposed on them in an ethical way. Research and development activities must also be carried out for orphan drugs. While pricing drugs, authorities must take pharmacoeconomic evaluations into account. Conclusion: Drugs must be accessible and in the first grade at all times under all circumstances because a product cannot replace it. The concept of surplus goods should be revised to ensure the common needs of the pharmaceutical industry, warehouses, and pharmacies. Promotions in the field by the pharmaceutical industry should be made based on scientific evidence in an ethical way. Inspectors should perform meticulous pharmaceutical industry inspections.

Authors and Affiliations

Murat ORAL, Gülbin ÖZÇELİKAY

Keywords

Related Articles

The Ameliorative Effects of Pycnogenol® on Liver Ischemia-Reperfusion Injury in Rats

Objectives: Pycnogenol® (PYC®), a standardized extract from the bark of Pinus maritima, consists of different phenolic compounds. PYC® has shown to have protective effects on chronic diseases such as diabetes, asthma, ca...

Development and Characterization of Insulin-loaded Liposome-chitosan-Nanoparticle (LCS-NP) Complex and Investigation of Transport Properties Through a Pancreatic Beta Tc Cell Line

Objectives: In recent years, studies on oral use have increased rapidly due to the restrictive aspects of parenteral administration of indispensable peptide-structured insulin in the rapidly growing worldwide treatment...

Biofabrication of Copper Nanoparticles: A Next-generation Antibacterial Agent Against Wound-associated Pathogens

Objectives: Impaired wound healing is a major complication. A few factors such as blood glucose level, poor circulation, immune system deficiency, and infection are the root causes of impaired wound healing. The aim of t...

Comparative Anatomical Studies on Three Endemic Ononis L. (Leguminosae) Species Growing in Turkey

Objectives: The leaf and stem anatomical characteristics of three endemic Ononis L. (Leguminosae) species were studied for the first time for the evaluated in terms of systematic of similarities and differences in these...

Design and Development of Crystallo-co-agglomerates of Ritonavir for the Improvement of Physicochemical Properties

Objectives: The aim of the present study was to obtain CCA of ritonavir to improve the solubility, dissolution rate, and other physicochemical properties. Materials and Methods: Ritonavir agglomerates were prepared using...

Download PDF file
  • EP ID EP381008
  • DOI 10.4274/tjps.88598
  • Views 129
  • Downloads 0

How To Cite

Murat ORAL, Gülbin ÖZÇELİKAY (2017). Ethical Overview of Pharmaceutical Industry Policies in Turkey from Various Perspectives. Turkish Journal of Pharmaceutical Sciences, 14(3), 264-273. https://europub.co.uk./articles/-A-381008